High levels of CXCL14 showed better overall survival (OS), recurrence-free survival (RFS), and distant metastasis-free survival (DMFS) in patients with breast cancer (Figure 1), indicating CXCL14 as a prognostic marker for favorable clinical outcomes in breast cancer. This evidence concerns the gene CXCL14 and breast cancer.